Dupilumab Maintains Long-Term Disease Control in Adults with Moderate-to-Severe Atopic Dermatitis as Measured by Well-Controlled Weeks: Results From the LIBERTY AD CHRONOS Clinical Trial.

ABSTRACT:

SUBMITTER: Wu JJ 

PROVIDER: S-EPMC8019003 | biostudies-literature | 2021 Apr

REPOSITORIES: biostudies-literature